Dengue hemorrhagic fever
Dengue hemorrhagic fever is a severe clinical type of dengue fever. The onset is similar to typical dengue fever. After 2 to 5 days of fever, the condition suddenly worsens, with massive bleeding and shock in multiple organs, hemoconcentration, thrombocytopenia, leukocytosis, and hepatomegaly. It is more common in adolescent patients and has a high mortality rate. Dengue hemorrhagic fever was first discovered in Thailand in 1950, and later epidemics occurred in Southeast Asia, the Pacific Islands, and the Caribbean. There are approximately 50 to 100 million cases of dengue fever worldwide each year, of which 500,000 cases progress to the more serious dengue hemorrhagic fever and dengue shock syndrome.
-
Site of disease:
Whole body skin -
Infectious :
Contagious -
Frequent population:
All can be affected, but it is more common in children -
Related symptoms:
Fever Headache Nausea and vomiting Fever Bleeding gums -
Concurrent disease:
Related Drugs
Aminobenzoic acid tablets
Indication: It is suitable for various bleeding caused by hyperactivity of fibrinase, such as abnormal bleeding during surgery and obstetrics and gynecology, and can also be used for purpura, leukemia, hemoptysis caused by tuberculosis, etc. It has a significant hemostatic effect on oozing blood. It has no hemostatic effect on severe hemorrhage (trauma, cancer, etc.). It can also be used for bleeding caused by excessive streptokinase or urokinase.
Manufacturer:
Hunan Dongting Pharmaceutical Co., Ltd.
Danazol Capsules
Indication: It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Related Ingredients
-
4-(Aminomethyl)benzoic acid list
56-91-7 -
Danazol list
17230-88-5